compared

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab

Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease…

2 weeks ago

Firms are optimistic about EXIM freight compared to domestic freight transported through railways- Dun & Bradstreet IRFA Report

MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, and Jupiter…

4 weeks ago

Firms are optimistic about EXIM freight compared to domestic freight transported through railways- Dun & Bradstreet IRFA Report

MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, and Jupiter…

4 weeks ago

Firms are optimistic about EXIM freight compared to domestic freight transported through railways- Dun & Bradstreet IRFA Report

MUMBAI, India, Nov. 26, 2024 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, and Jupiter…

4 weeks ago

Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban

November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…

1 month ago

Anthos Therapeutics Shares New Analysis from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban

November 16, 2024 16:38 ET | Source: Anthos Therapeutics Data presented at the American Heart Association Scientific Sessions show a…

1 month ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

November 11, 2024 01:00 ET | Source: Addex Therapeutics Nine-month Results Remain On Track for Net Profit Ad Hoc Announcement…

1 month ago